Demonstrates high enantioselectivity in cyclopropanation of heteroaryl alkenes, highlighting its scalability and safety.
Heteroaryl-functionalized chiral cyclopropanes are commonly found in pharmaceutically relevant molecules, yet their synthesis through catalytic asymmetric cyclopropanation presents multifaceted challenges concerning enantioselectivity, safety, and scalability. Herein, we report a homogeneous catalytic asymmetric cyclopropanation method by merging chiral pyridine bis-oxazoline (PyBox)-cobalt catalysts with readily accessible zinc carbenoids. This method enables facile access to chiral cyclopropanes bearing pyridyl, pyrimidyl, and other nitrogen-containing heterocyclic substituents with high enantioselectivities. Mechanistic studies support the direct transmetalation of the zinc carbenoid to the cobalt catalyst which then participates in cyclopropanation through a redox-neutral CoII catalytic cycle. The high enantioselectivity, homogeneity, and compatibility with various green solvents render this method amenable to scale up and application across diverse heteroaryl substrates.
No takes yet. Share an insight, caveat, or question.
Deem et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: